The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca; Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Nfe2L2 exon 2 and/or exon 3 loss from work conducted at Foundation Medicine. Provisional patent filed. (Inst)
SAVANNAH: A Phase II trial of osimertinib plus savolitinib for patients (pts) with EGFR-mutant, MET-driven (MET+), locally advanced or metastatic non-small cell lung cancer (NSCLC), following disease progression on osimertinib.
 
Geoffrey R. Oxnard
Honoraria - Bio-Rad; Chugai Pharma; Guardant Health; Sysmex
Consulting or Advisory Role - AstraZeneca; DropWorks; GRAIL; Ignyta; Inivata; LOXO; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)
 
Mireille Cantarini
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Paul Frewer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
George Hawkins
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Novartis
 
Jane Peters
No Relationships to Disclose
 
Paul Howarth
Employment - AstraZeneca
 
Ghada F. Ahmed
Employment - AstraZeneca
 
Tarjinder Sahota
Employment - AstraZeneca
 
Ryan Hartmaier
No Relationships to Disclose
 
Xiaocheng Li-Sucholeiki
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Novartis
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Alpha Pharmaceutical; AstraZeneca; Bristol-Myers Squibb; MSD; Ono Pharmaceutical